News
10 Nasdaq 100 Stocks With the Highest Short Interest
Last year was challenging in many respects for investors. The unprecedented coronavirus pandemic upended societal norms and rapidly transformed the traditional work environment. It also played at
3 Top Dividend Stocks With Yields Over 4%
When it comes to buying stocks, dividends are icing on the cake. Whatever your personal style of stock trading may be, incorporating dividend-paying companies into your portfolio is one of the most
5 Reasons to Buy Clover Health Stock Right Now
If you're looking for growth stocks that could make you rich, the health insurance industry probably isn't the first place you'd think to look. Over the past decade, though, companies working behind
Is Sundial Growers Stock the Next GameStop?
Shares of GameStop (NYSE: GME) soared more than 1,600% in January, even though the outlook for the video game retailer continues to look grim in what's become a more digital world for gamers. Retail
Here's the Surprising Coronavirus Stock You'll Really Want to Own
When most of us think of coronavirus stocks, we think of vaccine makers or companies developing therapeutics. We probably don't think of medical device players specializing in heart pumps.
Since
3 Questions to Answer Before Crossing Into the Social Security End Zone
OK, OK, you're shaking your head at the football metaphor. But if you're nearing retirement and have paid into Social Security all your life, you may be thinking of claiming benefits very soon. And
How Will the AMC and GameStop Sagas End? Just Ask Tilray
What are the four most dangerous words in investing? This time it's different.
That phrase implies that a person knows enough about what's happened in the past to think that what's going on now will
Is Pacific Biosciences of California a Ticking Time Bomb for Investors?
In the world of genome sequencing, Illumina (NASDAQ: ILMN) is the undisputed market leader. Pacific Biosciences of California (NASDAQ: PACB), or PacBio, has been viewed as more of an also-ran since
Will Oscar Be the Next Lemonade?
2020 was a great year for IPOs. There were 480 of them, the highest ever in one year, despite the global economic downturn and volatility of the stock market.
One high profile IPO was home
Are These 5 Beaten-Down Nasdaq Stocks Ready to Surge in 2021?
Over the past year, the Nasdaq Composite index has surged by 45%. Most of the gains can be attributed to stocks that have done well in the stay-at-home and remote work environments of the COVID-19
7 Celebrity Investors Who Spoke Out on the Raging War on Wall Street
It's a David and Goliath story of the modern age. A rogue group of individual investors band together in an online community and decide to take down hedge funds that profit from companies failing
3 Value Stocks That'll Make You Richer in February (and Beyond)
For more than a decade, growth stocks have been virtually unstoppable. Historically low lending rates have allowed companies to aggressively borrow in order to hire, innovate, and acquire other
Turned Off by the GameStop Hysteria? 3 Top Stocks to Buy Instead
Given the massive trading volume that GameStop (NYSE: GME) shares have seen over the past few days, there's clearly a huge appetite for explosively volatile stocks. I'll admit that it's exciting to
Why Vertex Pharmaceuticals' Solid Q4 Results Weren't Good Enough
What's it going to take for Vertex Pharmaceuticals (NASDAQ: VRTX) to regain its mojo? Shares of the big biotech have a long way to go to recapture the highs set last year before Vertex reported
Will Pfizer's Latest Bad News Wipe Out a Big Chunk of Its COVID Vaccine Profits?
The good times can't keep rolling forever. Pfizer (NYSE: PFE) just found that out the hard way.
Nearly everything seems to have gone Pfizer's way over the past three months. Pfizer and its partner
Investors Take Note: These Are the Biggest Challenges Facing Healthcare Disruptors
Can Amazon's (NASDAQ: AMZN) new service, Amazon Pharmacy, supplant brick-and-mortar retailers like CVS Health (NYSE: CVS)and Walgreens Boots Alliance (NASDAQ: WBA)? As it turns out, it's not easy to
Is Moderna Stock a Buy or Sell After Johnson & Johnson's Vaccine News?
Moderna (NASDAQ: MRNA) and the Pfizer/BioNTech partnership might not enjoy a duopoly in the U.S. COVID-19 vaccine market for much longer. Johnson & Johnson (NYSE: JNJ) announced late-stage results
5 Ultra-Popular Stocks to Avoid Like the Plague in February
We've turned the page on 2020, but that doesn't mean we left last year's volatility at the doorstep. If anything, Wall Street and investors have been made well aware of the uncertainty still
Scared of the Stock Market? Don't Be. Here Are 3 Investing Myths Debunked.
The stock market can be intimidating even for experienced investors, and it's easy to feel overwhelmed if you're new to the world of investing. There are also several myths surrounding the stock
Why Warren Buffett Will Never Get Short-Squeezed, in His Own Words
Whenever something big hits the financial markets, many people turn to legendary investor Warren Buffett for guidance. The Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO has had a successful
5 Top Stocks for February
If you made a few New Year's resolutions for 2021, I've got some bad news for you -- nearly 80% of people abandon their resolutions by the second week of February. The good news is that if you set
The 3 Most Important Earnings Reports in February
Earnings season is at its peak right now, and with January now behind us, investors are trying to figure out what the rest of 2021 is going to look like. The market lost its momentum toward the end
Kemper Corp (KMPR) Q4 2020 Earnings Call Transcript
Wells Fargo CEO's Pay Fell 12% in 2020
As a big bank goes, so goes its CEO compensation.
That, at least, is the dynamic at the most troubled of the big four American banks, Wells Fargo (NYSE: WFC). Last year, the company paid leader
Why Niu Technologies Shares Jumped 56% Last Month
Shares of Niu Technologies (NASDAQ: NIU) jumped last month as the Chinese electric-scooter maker got a boost from a strong fourth-quarter sales report. Investors also continued to be bullish on the